FRANKLIN RESOURCES INC - 31 Dec 2025 SCHEDULE 13G/A Report for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)

Filing Manager
FRANKLIN RESOURCES INC
Reporting Manager
Franklin Resources, Inc.
Security
Benitec Biopharma Inc. Common Stock, par value $0.0001
Symbol
BNTC
Shares outstanding
35,393,481 shares
Disclosed Ownership
3,751,709 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
29 Jan 2026, 11:34:07 UTC
Date of event
31 Dec 2025
Previous filing
04 Nov 2025
SEC
View on sec.gov

Key filing fact

FRANKLIN RESOURCES INC disclosed 11% ownership in Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC) on 31 Dec 2025.

Key facts

  • FRANKLIN RESOURCES INC filed SCHEDULE 13G/A for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC).
  • Disclosed ownership: 11%.
  • Date of event: 31 Dec 2025.

Change

  • Previous schedule filing date: 04 Nov 2025.
  • Current filing was accepted on 29 Jan 2026, 11:34.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Franklin Resources, Inc. 11% 3,751,709 3,751,709 0 /s/Thomas C. Mandia Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc.
Charles B. Johnson 0% 0 0 0 /s/Thomas C. Mandia Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney
Rupert H. Johnson, Jr. 0% 0 0 0 /s/Thomas C. Mandia Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney
Franklin Advisers, Inc. 11% 3,751,709 3,751,709 0 /s/Thomas C. Mandia Thomas C. Mandia, Assistant Secretary of Franklin Advisers, Inc.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .